These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 28089128
1. Management of Paget's Disease of the Calcaneum. Humphrey J, Pervez A, Walker R, Abbasian A, Singh S. J Foot Ankle Surg; 2017; 56(2):401-403. PubMed ID: 28089128 [Abstract] [Full Text] [Related]
2. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy. Peris P, Alvarez L, Vidal S, Martínez MA, Monegal A, Guañabens N. Clin Exp Rheumatol; 2007; 25(2):206-10. PubMed ID: 17543143 [Abstract] [Full Text] [Related]
4. Persistent effect of zoledronic acid in Paget's disease. Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F. Clin Exp Rheumatol; 2007 Jul; 25(3):464-6. PubMed ID: 17631747 [Abstract] [Full Text] [Related]
5. Unusual presentation of Paget's disease of bone. Sathyakumar S, Kapoor N, Hephzibah J, Paul TV. BMJ Case Rep; 2016 Mar 04; 2016():. PubMed ID: 26944376 [No Abstract] [Full Text] [Related]
6. Monostotic Paget's disease involving the calcaneus. Diagnostic and therapeutic problems. Two case-reports. Perrot S, Mortier E, Renoux M, Job-Deslandre C, Menkès CJ. Rev Rhum Engl Ed; 1995 Jan 04; 62(1):45-7. PubMed ID: 7788323 [Abstract] [Full Text] [Related]
7. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone. Whitson HE, Lobaugh B, Lyles KW. Bone; 2006 Oct 04; 39(4):954-8. PubMed ID: 16769264 [Abstract] [Full Text] [Related]
8. [Diagnosis and management of Paget's disease of bone]. Hashimoto J, Yoshikawa H. Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():56-64. PubMed ID: 18161082 [No Abstract] [Full Text] [Related]
9. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. Abelson A. Curr Med Res Opin; 2008 Mar 28; 24(3):695-705. PubMed ID: 18226324 [Abstract] [Full Text] [Related]
10. Paget's disease and bisphosphonates. Rendina D, De Filippo G, Mossetti G. N Engl J Med; 2005 Dec 15; 353(24):2616-8; author reply 2616-8. PubMed ID: 16365936 [No Abstract] [Full Text] [Related]
11. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR. J Bone Miner Res; 2007 Jan 15; 22(1):142-8. PubMed ID: 17032148 [Abstract] [Full Text] [Related]
12. [Treatment of Paget's disease of bone with zoledronic acid]. Body JJ, Sternon J. Rev Med Brux; 2005 Jan 15; 26(6):513-7. PubMed ID: 16454155 [Abstract] [Full Text] [Related]
13. Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget's Disease of Bone. Reid IR, Maslowski K. Calcif Tissue Int; 2017 Jul 15; 101(1):43-49. PubMed ID: 28324123 [Abstract] [Full Text] [Related]
14. Paget's disease: a clinical review. Shah M, Shahid F, Chakravarty K. Br J Hosp Med (Lond); 2015 Jan 15; 76(1):25-30. PubMed ID: 25585180 [Abstract] [Full Text] [Related]
15. Active Paget's disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature. Gkouva L, Andrikoula M, Kontogeorgakos V, Papachristou DJ, Tsatsoulis A. Clin Rheumatol; 2011 Jan 15; 30(1):139-44. PubMed ID: 20886248 [Abstract] [Full Text] [Related]
16. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis. Al Nofal AA, Altayar O, BenKhadra K, Qasim Agha OQ, Asi N, Nabhan M, Prokop LJ, Tebben P, Murad MH. Osteoporos Int; 2015 Jul 15; 26(7):1875-91. PubMed ID: 26037791 [Abstract] [Full Text] [Related]